Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis.
- Income Statement
- Quarterly
All numbers in thousands USD
Period Ending | 31 Oct 2024 | 31 Jul 2024 | 30 Apr 2024 | 31 Jan 2024 |
|---|---|---|---|---|
Total Revenue | 35,082,000 | 30,040,000 | 26,044,000 | 22,103,000 |
Cost of Revenue | 8,926,000 | 7,466,000 | 5,638,000 | (2,321,000) |
Gross Profit | 26,156,000 | 22,574,000 | 20,406,000 | 28,126,000 |
Operating Expenses | ||||
Research Development | 3,390,000 | 3,090,000 | 2,720,000 | (3,915,000) |
Selling General and Administrative | 897,000 | 842,000 | 777,000 | (1,255,000) |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | 0 | (50,000) |
Total Operating Expenses | 4,287,000 | 3,932,000 | 3,497,000 | (5,220,000) |
Operating Income or Loss | 21,869,000 | 18,642,000 | 16,909,000 | 13,615,000 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (36,000) | (189,000) | (75,000) | (294,000) |
Earnings Before Interest And Taxes | 22,309,000 | 19,275,000 | 17,343,000 | 13,572,000 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 22,316,000 | 19,214,000 | 17,279,000 | 13,703,000 |
Income Tax Expense | 3,000,000 | 2,615,000 | 2,400,000 | (4,738,000) |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 19,309,000 | 16,599,000 | 14,879,000 | 12,286,000 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 2,000 | 0 |
Net Income | 19,309,000 | 16,599,000 | 14,881,000 | 12,286,000 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 19,309,000 | 16,599,000 | 14,881,000 | 12,286,000 |